PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
74.68
+2.32 (3.21%)
At close: Feb 6, 2026, 4:00 PM EST
76.39
+1.71 (2.29%)
After-hours: Feb 6, 2026, 6:59 PM EST

PTC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5,9963,4812,0802,7862,8164,164
Market Cap Growth
72.46%67.40%-25.35%-1.06%-32.38%40.68%
Enterprise Value
6,7814,9403,2533,6713,2074,102
Last Close Price
74.6845.1427.5638.1739.8361.03
PS Ratio
3.294.322.223.995.2310.94
PB Ratio
--3.17-2.54-8.031958.208.64
EV/Sales Ratio
3.816.123.475.255.9510.77
Debt / Equity Ratio
-16.00-2.25-2.72-4.21882.732.28
Asset Turnover
0.790.450.520.380.260.20
Inventory Turnover
11.3922.0227.9536.9733.1723.33
Quick Ratio
2.212.261.901.391.744.23
Current Ratio
2.322.352.021.711.874.44
Return on Equity (ROE)
-----216.75%-81.42%
Return on Assets (ROA)
25.70%-5.09%-12.13%-15.09%-11.30%-11.21%
Return on Capital Employed (ROCE)
51.90%-13.10%-27.00%-33.90%-26.20%-17.80%
Earnings Yield
12.54%-10.44%-30.13%-20.06%-18.61%-10.52%
FCF Yield
11.76%-3.28%-8.98%-13.95%-9.93%-5.09%
Buyback Yield / Dilution
-10.56%-2.68%-4.33%-1.79%-6.72%-12.17%
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q